US Biotech appoints Aagami for supporting their out-licensing and partnering needs in India and other emerging markets

Published : 01 Mar 2013


Today, a US Biotechnology company from Baton Rouge, Louisiana appointed Aagami for its out-licensing and partnering needs in India, and other emerging, high growth markets. The client company specializes in innovative cancer treatment and their mission is to improve the overall patient condition through innovative bioimmunotherapy with proven treatment protocols, to lower deaths associated with cancer and reduce the cost of cancer treatment. 

 With a dedicated team in India, Aagami looks forward to put its best foot forward in supporting the new client in achieving success with its India and other emerging markets initiatives.


×
Twitter